Jose Borromeo, MD
Vascular Surgery · West Des Moines, IANPI 1497724371
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,579 of the $4,221 with a category attached, or 84.8%. It is spread thinly across 20 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for vascular surgery clinicians in IA, where the typical reported total is $5,435.
Across 54 payments — averaging $78.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Silk Road Medical, Inc.$1K
- Penumbra, Inc.$589
- W. L. Gore & Associates, Inc.$564
- Terumo Medical Corporation$354
- Abbott$336
- Shockwave Medical, Inc$223
- plus $1K from 14 others
Across 6 payments — averaging $3750.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Artivion, Inc.$23K
What the payments were for
- Travel & lodging$64215%
- Food & beverage$3,57985%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Silk Road Medical, Inc. | 7 | $1,002 |
| Penumbra, Inc. | 4 | $589 |
| W. L. Gore & Associates, Inc. | 4 | $564 |
| Terumo Medical Corporation | 4 | $354 |
| Abbott | 2 | $336 |
| Shockwave Medical, Inc | 2 | $223 |
| Medtronic | 1 | $174 |
| Lemaitre Vascular, Inc. | 12 | $168 |
| Artivion, Inc. | 4 | $161 |
| Bard Peripheral Vascular, Inc. | 1 | $148 |
| Edwards Lifesciences | 1 | $133 |
| Biocompatibles, Inc. | 1 | $110 |
| Philips North America LLC | 1 | $73 |
| Cook Medical LLC | 2 | $41 |
| Johnson & Johnson | 3 | $37 |
| Boston Scientific | 1 | $32 |
| Angiodynamics, Inc. | 1 | $23 |
| Asahi Intecc USA, Inc. | 1 | $19 |
| Urgo Medical North America, LLC | 1 | $17 |
| Itamar Medical Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$921
- ENROUTE Transcarotid Stent System$745
- ENHANCE Transcarotid Peripheral Access Kit$745
- ENROUTE 0.014 Guidewire$745
- Indigo System$312
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$263
- Indigo$209
- ESPRIT$198
- ENROUTE Transcarotid Stent$176
- CONCERTOTM$174
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$164
- GORE TAG Thoracic Branch Endoprosthesis$158
- WAVELINQ$148
- Azur CX Detachable$144
- Conformable TAG Thoracic Endoprosthesis$144
- JETi Peripheral Catheter$138
- EV1000 Clinical Platform$133
- VARITHENA$110
How this compares
$4,221 in reported general payments places this provider in the 40th percentile of 38 vascular surgery providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 50 | $35,091 |
| EliquisApixaban | 31 | $21,581 |
| Rosuvastatin Calcium | 35 | $665 |
| ClopidogrelClopidogrel Bisulfate | 63 | $569 |
| Cilostazol | 30 | $553 |
| Bupropion XlBupropion Hcl | 12 | $66 |
| Atorvastatin Calcium | 12 | $47 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $37 | $35,09150 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 38 vascular surgery providers in Iowa.
Other vascular surgery in West Des Moines
- Douglas MassopWest Des Moines$590K
- Eric ScottWest Des Moines$393K
- David ChewWest Des Moines$43K
- Nicholas SouthardWest Des Moines$27K
- Dennis FryWest Des Moines$12K
- Zane YoungWest Des Moines$8K
- Woosup ParkWest Des Moines$6K
- Rori MankinsWest Des Moines$5K
- Harold HsuWest Des Moines$4K
- James EbaughWest Des Moines$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.